Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 699 | 320 | 396 | 293 | 558 |
| Operating Income | -699 | -320 | -396 | -293 | -558 |
| Other Income | 1 | 2 | 1 | -1 | 0 |
| Pre-tax Income | -699 | -318 | -395 | -295 | -559 |
| Net Income Continuous | -699 | -318 | -395 | -295 | -559 |
| Net Income | $-699 | $-318 | $-395 | $-295 | $-559 |
| EPS Basic Total Ops | -0.25 | -0.25 | -0.26 | -0.25 | -0.24 |
| EPS Basic Continuous Ops | -0.25 | -0.25 | -0.26 | -0.25 | -0.24 |
| EPS Diluted Total Ops | -0.25 | -0.25 | -0.26 | -0.25 | -0.24 |
| EPS Diluted Continuous Ops | -0.25 | -0.25 | -0.26 | -0.25 | -0.24 |
| EBITDA(a) | $-683 | $-303 | $-379 | $-274 | $-543 |